Canadian Biosample Repository , Canada

Certification Status: Checklist Required

Registration Status: Completed

Objective: CBSR provides shipping, processing, storage, and retrieval of biological samples on a cost recovery basis for Investigators. Our capabilities and protocols are flexible and customizable to your individual project to ensure the samples collected are the samples you need. Our storage facility is highly secure with access logging, security cameras, temperature/environmental monitoring, and freezers connected to the university central alarm system. Ownership is retained by the Investigators who collected the sample; only they can authorize retrieval from our facility. The 831,600 samples stored at our facility are tracked using CBSR's own software, Biobank. Samples are given a unique identifier in software and assigned a location in our freezers. Biobank rapidly generates lists of requested samples so we can pull more than a thousand samples a day. Biobank is an open source collaboration between CBSR, & Ontario Health Services, available for free on GitHub along with several other open source tools we have developed.

Registered Biobank Name	Canadian Biosample Repository
Biobank Leader	CBSR Tech
Country	Canada
Email for biobank inquiries	tech@biosample.ca
Principal Investigator	Bruce Ritchie
Website	biosample.ca
User Type Mono: A biobank that supports a specific research project, may have few staff members, a small-scale accrual scope with little to no initial intention of releasing or distributing biospecimens to secondary parties Oligo: A biobank that supports several research groups or clinical trials, may or may not be designed to release biospecimens outside their collaborative group Poly: A biobank that has generally a larger accrual scope, resources, and multiple users outside the biobank proper	Oligo - Collection aimed at supporting several research projects, a research group or a research consortium

Biospecimen Collected:

Cohort Highlights

100 cases Next Generation Sequencing assay to detect all classes of genetic variant in Lung Cancer using a single Diagnostic test.
200 cases Colorectal TMA for QC purposes in support of study of tumor infiltrating lymphocytes in ovarian cancer tissues.
Build 300 cases breast cancer TMA containing primary tumour and matched metastatic LN for various subtypes (luminal, HER2, Triple negative). Start with Triple negatives.
125 cases Breast tumour and metastatic lymph nodes in breast cancer cases with outcomes of metastasis to lung or bone.
100 cases of rare tumours - fibrolamellar hepatocellular carcinoma. FFPE, frozen, BC.
200 cases of FFPE tissue sections from breast, lung adenocarcinoma, and lung squamous cell carcinoma with matching normal tissue (only pathology data requested).